Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mary F. Otterness"'
Autor:
Elaine Hogan-Miller, Alice J. Stark, Mark S. Wathen, Alfred E. Buxton, PainFREE Rx Ii Investigators, Mary F. Otterness, Mark E. Josephson, Paul J. Degroot, Michael O. Sweeney
Publikováno v:
Journal of the American College of Cardiology. 46(2):310-316
ObjectivesThe aim of this study was to determine whether QRS duration (QRSd) correlates with occurrence of ventricular arrhythmia in patients with coronary disease (CAD) receiving implantable cardioverter-defibrillators (ICDs).BackgroundA QRSd measur
Publikováno v:
Pharmaceutical Statistics. 3:25-37
In early clinical development of new medicines, a single-arm study with a limited number of patients is often used to provide a preliminary assessment of a response rate. A multi-stage design may be indicated, especially when the first stage should o
Autor:
Kent J. Volosin, Mark S. Wathen, Mary F. Otterness, Alice J. Stark, Ismaile Abdalla, Michael O. Sweeney, Paul J. Degroot
Publikováno v:
Circulation. 111(22)
Background— Implantable cardioverter defibrillators (ICDs) reduce mortality in primary and secondary prevention. Quality of life, mortality, appropriate therapies for specific ventricular rhythms, and inappropriate therapies for supraventricular ta
Autor:
John M. Morgan, Laurence D. Sterns, Mary F. Otterness, Kevin T. Ousdigian, Jodi L Hanson, Bruce L. Wilkoff
Publikováno v:
Current Controlled Trials in Cardiovascular Medicine
Current Controlled Trials in Cardiovascular Medicine, Vol 5, Iss 1, p 12 (2004)
Current Controlled Trials in Cardiovascular Medicine, Vol 5, Iss 1, p 12 (2004)
The delivery of implantable cardioverter defibrillator (ICD) therapy is sophisticated and requires the programming of over 100 settings. Physicians tailor these settings with the intention of optimizing ICD therapeutic efficacy, but the usefulness of
Autor:
Robert C. Canby, Mary F. Otterness, Kent J. Volosin, Mark S. Wathen, Alice J. Stark, Donald S. Rubenstein, Paul J. Degroot, Wayne O. Adkisson, Koroush Khalighi, Christian Machado, Michael O. Sweeney
Publikováno v:
Circulation. 110(17)
Background— Successful antitachycardia pacing (ATP) terminates ventricular tachycardia (VT) up to 250 bpm without the need for painful shocks in implantable cardioverter-defibrillator (ICD) patients. Fast VT (FVT) >200 bpm is often treated by shock
Publikováno v:
Heart Rhythm. 3:S155-S156
Autor:
Paul J. Degroot, Alice J. Stark, Mary F. Otterness, Ismaile Abdalla, Michael O. Sweeney, Mark S. Wathen
Publikováno v:
Journal of the American College of Cardiology. 43:A125
Autor:
Herwig Schmidinger, Stefan H. Hohnloser, Santini Massimo, Mary F. Otterness, Anne M. Gillis, Deborah J Kavaney, Kevin Wolfe, Gem Iii At Worldwide Investigators, Christina Unterberg-Buchwald
Publikováno v:
Journal of the American College of Cardiology. (9):1653-1659
ObjectivesThis study evaluated the safety and efficacy of atrial pacing therapies for the treatment and prevention of atrial tachycardia (AT) or atrial fibrillation (AF) in a new dual chamber implantable cardioverter defibrillator (ICD).BackgroundPat
Autor:
Mark S. Wathen, Alice J. Stark, Alfred E. Buxton, Michael O. Sweeney, Elaine Hogan Miller, Mary F. Otterness
Publikováno v:
Journal of the American College of Cardiology. (5):A29